---
title: "Social Determinants of Health Are More Common in HIV/HBV Coinfection Than in HIV or HBV Alone"
id: "medrxiv-17-social-determinants-of-health-in-hiv-hbv-coinfection-compared-with-hiv-and-hbv"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-social-determinants-of-health-in-hiv-hbv-coinfection-compared-with-hiv-and-hbv"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.31.26361856v1?rss=1"
published_at: "2026-09-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Social Determinants of Health Are More Common in HIV/HBV Coinfection Than in HIV or HBV Alone
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-social-determinants-of-health-in-hiv-hbv-coinfection-compared-with-hiv-and-hbv
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.31.26361856v1?rss=1)
- **Published At:** 2026-09-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- A retrospective cohort study used TriNetX data from 110 U.S. healthcare organizations (2010–2026) to compare newly documented **social determinants of health** (SDoH) in adults with **HIV/HBV coinfection** versus matched adults with HIV or HBV monoinfection. - Investigators propensity score matched cohorts: 10,071 HIV/HBV patients matched to HIV-only, and 9,659 HIV/HBV patients matched to HBV-only; mean age ~47 years, 79% male, 66% non-White; median follow-up 3.3 years. - The study organized SDoH using a dynamic individual-level framework with four domains: **material vulnerability**, **healthcare access and engagement**, **interpersonal adversity**, and **psychosocial vulnerability**. - Over 178,900 person-years, the primary SDoH composite incidence was higher in HIV/HBV than in HIV (11.5% vs 9.7%; incidence 2.50 vs 1.97 per 100 person-years; HR 1.25, 95% CI 1.15–1.37) and than in HBV (11.0% vs 6.4%; incidence 2.39 vs 1.67 per 100 person-years; HR 1.50, 95% CI 1.35–1.67). - HIV/HBV was associated with higher rates of **material vulnerability** and **healthcare access and engagement** outcomes in both comparisons; specific indicators included housing instability, food insecurity, financial insecurity, insurance instability, and care disengagement/nonadherence (HR range vs HIV: 1.22–3.33; vs HBV: 1.31–1.94). - In the HBV comparison, HIV/HBV was additionally associated with increased **interpersonal adversity**, primary support stressors, and violence or victimization (HR range 1.36–2.16). - Findings were reported as robust across sensitivity analyses. The authors conclude HIV/HBV is associated with more newly documented SDoH than monoinfection and recommend dynamic assessment of SDoH. - IRB/ethics: Deidentified TriNetX data were used with a waiver from WCG IRB. Funding sources included NIAID grants listed in the manuscript. Competing interests: none declared.
## Clinical Analysis & Structured Key Points
Social Determinants of Health in HIV/HBV Coinfection Compared with HIV and HBV Monoinfection: A Framework for Dynamic Social Vulnerability | medRxiv Skip to main content Social Determinants of Health in HIV/HBV Coinfection Compared with HIV and HBV Monoinfection: A Framework for Dynamic Social Vulnerability View ORCID Profile George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Michael Freeman , Chari Cohen , Ighovwerha Ofotokun , Karine Dube doi: https://doi.org/10.64898/2026.08.31.26361856 George Yendewa 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for George Yendewa For correspondence: gay7{at}case.edu Tayoot Chengsupanimit 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ali Dehghani 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ali Ahmed 2 University of Pennsylvania; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amir Mohareb 3 Harvard Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Michael Freeman 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chari Cohen 4 Hepatitis B Foundation Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ighovwerha Ofotokun 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Karine Dube 2 University of Pennsylvania; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection is associated with accelerated liver disease, but whether coinfection is associated with newly documented social determinants of health (SDoH) is unclear. We conducted a retrospective cohort study using TriNetX across 110 U.S. healthcare organizations (2010-2026). We propensity score matched adults with HIV/HBV to adults with HIV or HBV monoinfection. We organized newly documented SDoH indicators using a dynamic individual-level framework with four clinically recognized domains of social disadvantage: material vulnerability, healthcare access and engagement, interpersonal adversity, and psychosocial vulnerability. Matched cohorts included 10,071 HIV/HBV-HIV pairs and 9,659 HIV/HBV-HBV pairs (mean age, 47 years; 79% male; 66% non-White; median follow-up, 3.3 years). Over 178,900 person-years, HIV/HBV was associated with higher risk of the primary SDoH composite compared with HIV (11.5% vs 9.7%; incidence rate, 2.50 vs 1.97 per 100 person-years; hazard ratio [HR], 1.25; 95% confidence interval [CI], 1.15-1.37) and HBV (11.0% vs 6.4%; incidence rate, 2.39 vs 1.67; HR, 1.50; 95% CI, 1.35-1.67). HIV/HBV was also associated with higher material vulnerability and healthcare access and engagement composites in both comparisons, including housing instability, food insecurity, financial insecurity, insurance instability, and care disengagement/nonadherence (HR range, 1.22-3.33 vs HIV; 1.31-1.94 vs HBV). In the HBV comparison, HIV/HBV was additionally associated with interpersonal adversity, primary support stressors, and violence or victimization (HR range, 1.36-2.16). Findings were robust across sensitivity analyses. HIV/HBV was associated with more newly documented SDoH than monoinfection, supporting dynamic SDoH assessment. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Deidentified individual participant data that underlie the results were extracted from TriNetX, a federated national health research network with data sourced from 110 health care organizations within the United States with waiver from WCG IRB I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared NIAID , 5UM1AI069501 , P30AI036219 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 02, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Social Determinants of Health in HIV/HBV Coinfection Compared with HIV and HBV Monoinfection: A Framework for Dynamic Social Vulnerability Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Social Determinants of Health in HIV/HBV Coinfection Compared with HIV and HBV Monoinfection: A Framework for Dynamic Social Vulnerability George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Michael Freeman , Chari Cohen , Ighovwerha Ofotokun , Karine Dube medRxiv 2026.08.31.26361856; doi: https://doi.org/10.64898/2026.08.31.26361856 Share This Article: Copy Citation Tools Social Determinants of Health in HIV/HBV Coinfection Compared with HIV and HBV Monoinfection: A Framework for Dynamic Social Vulnerability George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Michael Freeman , Chari Cohen , Ighovwerha Ofotokun , Karine Dube medRxiv 2026.08.31.26361856; doi: https://doi.org/10.64898/2026.08.31.26361856 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (614) Allergy and Immunology (896) Anesthesia (327) Cardiovascular Medicine (4772) Dentistry and Oral Medicine (474) Dermatology (407) Emergency Medicine (643) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1615) Epidemiology (15838) Forensic Medicine (32) Gastroenterology (1195) Genetic and Genomic Medicine (6984) Geriatric Medicine (727) Health Economics (1057) Health Informatics (4988) Health Policy (1427) Health Systems and Quality Improvement (1738) Hematology (581) HIV/AIDS (1336) Infectious Diseases (except HIV/AIDS) (16245) Intensive Care and Critical Care Medicine (1161) Medical Education (663) Medical Ethics (151) Nephrology (721) Neurology (7196) Nursing (364) Nutrition (1074) Obstetrics and Gynecology (1232) Occupational and Environmental Health (1001) Oncology (3575) Ophthalmology (1038) Orthopedics (393) Otolaryngology (446) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1774) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5836) Public and Global Health (9694) Radiology and Imaging (2389) Rehabilitation Medicine and Physical Therapy (1435) Respiratory Medicine (1243) Rheumatology (635) Sexual and Reproductive Health (767) Sports Medicine (577) Surgery (767) Toxicology (107) Transplantation (303) Urology (286)
## Related Clinical Research

- [HBsAg clearance and occult HBV mutation in HIV/HBV-coinfected patients on ART](https://medichelpline.com/clinical-feed/medrxiv-7-hepatitis-b-surface-antigen-clearance-in-hiv-hbv-coinfected-patients-associated.md)
- [Social Vulnerability and Risk of Mortality, Liver Disease, and Organ Complications in US Adults Wi](https://medichelpline.com/clinical-feed/medrxiv-19-multidimensional-social-vulnerability-and-hepatic-and-extrahepatic-outcomes-in.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [Strategies to improve access to pediatric HIV services in Malawi: study protocol](https://medichelpline.com/clinical-feed/pubmed-42691038.md) (DOI: 10.1371/journal.pone.0357408)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.